Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Ambroxol

Ambroxol

pharmaceutical raw materials
Ambroxol structure

Ambroxol 

structure
  • CAS No:

    18683-91-5

  • Formula:

    C13H18Br2N2O

  • Chemical Name:

    Ambroxol

  • Synonyms:

    Cyclohexanol,4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-,trans-;Cyclohexanol,4-[(2-amino-3,5-dibromobenzyl)amino]-,trans-;trans-4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol;N-(trans-4-Hydroxycyclohexyl)-N-(2-amino-3,5-dibromobenzyl)amine;NA 872;N-(trans-4-Hydroxycyclohexyl)-2-amino-3,5-dibromobenzylamine;Ambroxol;2-Amino-3,5-dibromo-N-(trans-4-hydroxycyclohexyl)benzylamine;Lasolvan;Ambroxils;12674-29-2

  • Categories:

    Active Pharmaceutical Ingredients  >  Respiratory Drugs

Description

Ambroxol (NA-872) is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus.


Ambroxol is an aromatic amine.|Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an important role in the body’s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.|A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Ambroxol Basic Attributes

378.1

378.10

242-500-3

200168S0CL|QH6ZT6J071

DTXSID8022583

R05CB06|R - Respiratory system

2922199090

Characteristics

58.3

2.91

1.5863 (rough estimate)

233-234 C

468.6±45.0 °C(Predicted)

237.2±28.7 °C

1.6220 (estimate)

>56.7 [ug/mL]

2-8°C

0mmHg at 25°C

Oral-rat LD50: 13400 mg/kg; Oral-Mouse LD50: 2720 mg/kg

Flammable; burning produces toxic nitrogen oxides and bromide fumes

Safety Information

3

22-36/37/38

36-26

GV8423000

Xn,Xi

Warehouse ventilated, low temperature and dry

P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 3 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

moderately

Approximately 90%

Drug Information

Ambroxol is indicated for secretolytic therapy in bronchoplmonary diseaes with abnormal mucus secretion and transport. It allows the mucus to be more easily cleared and ease a patient's breathing.

Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)

Rapid and almost complete.

Ambroxol has known human metabolites that include 2-Amino-3,5-dibromobenzaldehyde and 4-Aminocyclohexanol, cis-.

7-12 hours

Ambroxol is a mucolytic agent. Excessive Nitric oxide (NO) is associated with inflammatory and some other disturbances of airways function. NO enhances the activation of soluble guanylate cyclase and cGMP accumulation. Ambroxol has been shown to inhibit the NO-dependent activation of soluble guanylate cyclase. It is also possible that the inhibition of NO-dependent activation of soluble guanylate cyclase can suppress the excessive mucus secretion, therefore it lowers the phlegm viscosity and improves the mucociliary transport of bronchial secretions.

4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol

Ambroxol Use and Manufacturing

Uses

expectorant. For acute and chronic bronchitis, bronchial asthma, bronchiectasis, emphysema, tuberculosis, pneumoconiosis, difficulty in sputum production after surgery, etc. This product injection can be used for the proactive treatment of postoperative pulmonary complications and the treatment of infant respiratory distress syndrome.

Pharmaceuticals

Computed Properties

Molecular Weight:378.10
XLogP3:2.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:377.97654
Monoisotopic Mass:375.97859
Topological Polar Surface Area:58.3
Heavy Atom Count:18
Complexity:259
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Related Drugs

Recommended Suppliers of Ambroxol

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.